The prevalence of Cupressaceae-Taxodiaceae pollen allergy has increased in the Mediterranean area in recent years [1, 2] . In order to assess the impact of this allergy in our area, we carried out a prospective, cross-sectional study at Terrassa Hospital, Vallés Occidental, Barcelona, Spain. The hospital is located in an urban district with more than 800 000 inhabitants. The objectives of this study were as follows: (1) to determine the annual incidence of sensitization to Cupressaceae pollen in the catchment population; (2) to describe the clinical characteristics and the molecular profile of sensitization; (3) to test the diagnostic performance of pollen extracts in skin prick testing (SPT), serum sIgE testing, and nasal provocation testing (NPT) for the diagnosis of cypress allergy.
After signing the informed consent document, patients with symptoms suggestive of respiratory allergy and a positive SPT result to ≥1 of the 3 extracts of cypress pollen tested (Cupressus sempervirens, Cupressus arizonica, and Juniperus ashei [Stallergenes]) were included in the study between February 1, 2010 and January 31, 2011. Demographic and clinical data were collected. Serum sIgE to the same 3 species (ImmunoCAP) and to molecular allergens (ImmunoCAP ISAC) was measured. NPT was performed with a J ashei extract (Stallergenes).
Symptoms and medication use were recorded in a diary, and cypress pollen concentrations were provided by Xarxa Aerobiologica de Catalunya (Aerobiology Network of Catalonia). A positive SPT result with Cupressaceae pollen and concordant respiratory symptoms were considered the gold standard. The statistical analysis was performed using SAS 9.4 and SAS Enterprise 6.1.
A total of 1278 new patients were evaluated. The incidence of sensitization to Cupressaceae pollen assessed by SPT was 15.1%, which decreased to 13.7% and 11% when the assessment was based on positive sIgE to complete extract and individual allergens, respectively.
The characteristics of Cupressaceae pollen-sensitized patients and the control group (sensitized to other aeroallergens) are shown in the Table, which highlights statistically significant differences between the groups, as follows: (1) male gender was more frequent in the Cupressaceae pollen-sensitized children (P=.04); (2) a family history of atopy was significantly more common in children than in adults in the control group (P<.0001); (3) sensitization to foods was significantly more frequent in the Cupressaceae pollen-sensitized patients (P=.0005), especially those sensitized to peach (9/122, 7.3%); and (4) monosensitization was more frequent in the control group (P<.0001). Cupressaceae pollen-sensitized patients were predominantly residents in urban areas (88.5%), where they had lived for an average of 22.1 years (range, 1-63 years). Most patients were polysensitized (97.6%), and the most frequently detected concurrent sensitizations were to grass and olive pollen.
Wheals and sIgE values induced by C arizonica and J ashei were wider than those induced by C sempervirens.
Most of the patients were asymptomatic (72%), and the most frequent symptoms were rhinoconjunctivitis (16%) and rhinitis (9%).
The molecular profiles of Cupressaceae pollen-sensitized patients revealed the following: (1) sensitization to crossreactive food allergens (lipid transfer protein, 29%; seed storage proteins, 16%) and low sensitization to profilin (9%), thaumatin (7%), and polcalcin (2%); and (2) a high percentage of sensitization to CCD-bearing proteins (Cup a 1, 91.4%; Cry j 1, 67%; Cyn d 1, 51%; Ole e 1 [known as nOle e 1 in ISAC112 in 2013; nowadays known as rOle e 1], 46.8%; Phl p 4, 30.8%; Pla a 2, 28.7%; Jug r 2, 11.7%; and MUFX3, 6.3%). Positivity to Ole e 1 (P=.025) and Jug r 2 (P=.04) was significantly associated with asymptomatic sensitization to Cupressaceae.
A total of 71 specific NPTs were carried out: 47 were positive (13 were allergic), 9 were negative, and 15 were positive to saline serum (nasal hyperreactivity). NPT was highly sensitive (100%) but not very specific (15%), except for the concentration of 1 IR (69%).
The incidence of sensitization to Cupressaceae and to the individual allergenic components in SPT was lower than (purified Juniperus ashei standardized by Jun a 1) for the nasal provocation tests was provided free by Stallergenes SA.
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